Skip to main content
. Author manuscript; available in PMC: 2015 Mar 25.
Published in final edited form as: Nature. 2014 Jul 16;513(7519):564–568. doi: 10.1038/nature13577

Figure 4. IL-23 inhibits the effects of IL-33 on Treg cells.

Figure 4

a, Naïve CD4+ T cells were cultured with anti-CD3/CD28 plus TGF-β1 as well as indicated cytokines and the frequencies of Foxp3+ T cells determined after 3 days later (mean ± s.e.m. of three independent experiments). b, Naïve CD4+ T cells were cultured with anti-CD3/CD28 plus indicated cytokines for 48h. Data are from one experiment representative of two (mean ± s.d.). c, Naïve CD4+ T cells were cultured as indicated. Representative blots of two independent experiments are shown. d, C57BL/6 Il23a−/−Rag1−/− mice were injected with CD45RBhi WT (n = 9) or St2−/− (n = 10) T cells. Mice were sacrificed after 6-8 weeks post transfer and frequencies of Foxp3+CD4+ T cells in colon are shown. e, Colitis scores for mice in (d). f, Expression of indicated cytokines by colonic CD4+ T cells from mice in (d). g, Treg cells were cultured with anti-CD3/CD28 for 24h followed by stimulation with IL-33 in the presence or absence of IL-23. Representative blots of two independent experiments are shown. h, Treg cells were cultured in the presence of anti-CD3/CD28 for 24h and mRNA expression of indicated genes measured following stimulation with IL-33 for 45 minutes in the presence or absence of IL-23 (mean ± s.e.m. of three independent experiments). i, Treg cells were cultured with anti-CD3/CD28 for 24h and representative blots of two independent experiments are shown. *P<0.05, **P<0.01 *** P<0.001 as calculated by 1way-ANOVA with Bonferroni post-test or Students’ t-test.

HHS Vulnerability Disclosure